Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Gate Neurosciences logo — Brain Health, Reimagined

Gate Neurosciences

Brain Health, Reimagined

Founded 2019 United States Indianapolis, United States 15 employees Series Unknown Total: $41.10M Biotechnology, Health Care +2

General Information

Company Name Gate Neurosciences
Founded Year 2019
Location United States Indianapolis, United States +1
Founders / Decision Makers
Team member
Employees 15
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Series Unknown
Social

Get notified when Gate Neurosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Gate Neurosciences

Gate Neurosciences, Inc. is a biotechnology and pharmaceutical startup established in 2018 with a mission to revolutionize brain health. Their slogan, "Brain Health, Reimagined," encapsulates their commitment to developing innovative therapies for the approximately 1 billion individuals globally afflicted by neuropsychiatric and cognitive disorders. Their unique approach involves the creation of rapid-acting drug mechanisms tailored to enhance synaptic function, strengthen neuronal connections, and restore healthy brain signaling, addressing the underlying disease biology. The company places significant emphasis on precision biomarkers and targeted patient populations, leveraging extensive clinical, preclinical, and translational data across thousands of patients with their proprietary molecules. Their visionary solutions and focus on redefining the possibilities in mental health treatment offer promise for better lives. In its most recent funding round on 05 October 2022, Gate Neurosciences, Inc. secured a substantial investment of $25.00M. The investors for this round include BioCrossroads, Innoviva, Thornapple River Capital, and Luson Bioventures, signifying the confidence prominent entities in the industry have in the startup's potential. Operating from the United States, Gate Neurosciences, Inc.'s clinical-stage, next-generation neuroscience pipeline stands as a testament to their dedication to reshaping the landscape of brain health treatment. For further information regarding their pioneering initiatives, interested individuals can visit their website at https://www.gateneuro.com.

Taxonomy: neuroscience, precision medicine, CNS therapies, brain health, neuropsychiatric disorders, cognitive disorders, rapid-acting drug mechanisms, synaptic function, neuronal connections, precision biomarkers, clinical-stage, precision medicine approaches, breakthrough drugs, mental health treatments, clinical trials

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 4
Investor Investor Investor
•••• •••• 		05 Oct 2022
Debt Financing •••••• - 09 Dec 2021
Debt Financing •••••• - 31 Jul 2020

Gate Neurosciences Alternatives & Competitors

Gate Neurosciences vs
Linus Health
Linus Health United States

Practical solutions for proactive brain health

Series B
120 employees
Health Care, Health and Wellness
Gate Neurosciences vs
Neumora
Neumora United States

Pioneering a new era of medicines for brain diseases

Series B
111 employees
Biotechnology, Health Care
Compare Gate Neurosciences vs Neumora
Gate Neurosciences vs
Medical Intelligence Learning Labs (Milli)
Medical Intelligence Learning Labs (Milli) United States

Helping every doctor gain the clinical wisdom to use precision medicine to prevent, halt, and revers...

2 employees

FAQ About Gate Neurosciences

Brain Health, Reimagined
Gate Neurosciences was founded in 2019.
Gate Neurosciences is headquartered in Indianapolis, United States.
Gate Neurosciences operates in the following industries: Biotechnology, Health Care, Life Sciences, Pharmaceutical.
Gate Neurosciences has approximately 15 employees.
Gate Neurosciences has completed 3 funding rounds, raising a total of $41.10M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Gate Neurosciences include Linus Health, Neumora, Medical Intelligence Learning Labs (Milli), Re:Cognition Health, Emugen Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gate Neurosciences and Linus Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Gate Neurosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy